Products for Research Use Only
RegisterLogin

Lulizumab

CAT: 0804-HY-P99302-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99302-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Lulizumab (Humanized Anti-CD28 Recombinant Antibody) is an anti-CD28 domain antibody antagonist. Lulizumab inhibits T-cell activation by selectively targeting the CD28 signal. In a sensitized non-human primate kidney transplantation model, when combined with Carfilzomib , Lulizumab can regulate immune cells and prolong the survival time of the graft[1][2].
CAS Number
2235419-62-0
Product Name Alternative
Humanized Anti-CD28 Recombinant Antibody
UNSPSC
12352203
Target
CD28
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/lulizumab.html
Purity
95.0
Solubility
H2O
Smiles
[Lulizumab]
Molecular Weight
(12.01 kDa)
References & Citations
[1]Fernandes JC. Therapeutic application of antibody fragments in autoimmune diseases: current state and prospects. Drug Discov Today. 2018 Dec;23 (12) :1996-2002.|[2]Schroder PM, et al. Preoperative carfilzomib and lulizumab based desensitization prolongs graft survival in a sensitized non-human primate model. Kidney Int. 2021 Jan;99 (1) :161-172.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
MBS5818743Lulizumab
T77074-01Lulizumab pegol
GTR18337964-01Lulizumab Antibody
048108CD28 (lulizumab) discontinued
GTR18337688-01Lulizumab pegol Antibody
WA3111Research Grade Lulizumab
E55B1219Lulizumab (Reference antibody)
F1385-5Anti-CD28 Antibody (Lulizumab)
KBI1445KRIBIOLISA™ Lulizumab Pegol ELISA
GTR18697914-01Lulizumab Human Monoclonal Antibody

Popular Products